Alternatives to Meta-Flux
Meta-Flux is a Biotechnology tool: AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions. Here are the 49 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Meta-Flux
Isomorphic Labs3.0 out of 5 (1)AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.
Insilico MedicineNot ratedA clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.
- EXExscientia3.0 out of 5 (1)
Pixelgen TechnologiesNot ratedA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
VizgenNot ratedSpatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.
LifeMine Therapeutics Inc.Not ratedClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
FreenomeNot ratedFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
Adaptyv BiosystemsNot ratedAutomated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.
Arc InstituteNot ratedA nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.
- EAEarendil LabsNot rated
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
Sinopia BiosciencesNot ratedBiotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
Transcripta BioNot ratedAI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.
Nimbus Therapeutics3.0 out of 5 (1)Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines.
Graph TherapeuticsNot ratedDeveloping precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.
- MOMolecular Glue LabsNot rated
Developing AI-powered solutions for drug discovery.
Houdini BioNot ratedEngineering-driven DNA design platform to overcome biological barriers in genetic medicines.
InduPro, Inc.Not ratedBiotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Mammoth BiosciencesNot ratedBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
Showing the next 20 closest matches. See the rest on the Meta-Flux profile.
Sponsored rows are paid and labelled. Advertise on this page
